Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05467150 · ClinicalTrials.gov registry record · NA
Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers
A NA study of Infant of Diabetic Mother, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05467150: Recruiting NA study of Infant of Diabetic Mother, sponsored by University of Minnesota.
NCT05467150 is a NA study of Infant of Diabetic Mother that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05467150, a NA study of Infant of Diabetic Mother, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by ERP performance in infants of diabetic mothers (IDMs), a cohort that is at-risk for recognition memory abnormalities.
Primary Outcome
At one month of age, an auditory recognition memory ERP will be performed. Components of interest will be the P200 amplitude (in microvolts) The P200 is a positive component of the ERP waveform and a measure of early perceptual processing of stimuli.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Probiotic Supplement
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05467150 shows while recruiting
NCT05467150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Infant of Diabetic Mother appearing as the primary indexed condition, and to 1 intervention - of which Probiotic Supplement is the first listed.
NCT05467150 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05467150 about?
NCT05467150 is a clinical study titled "Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers". The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by ERP performance in infants of diabetic mothers (IDMs), a cohort that is at-risk for recognition memor...
What is the current status of trial NCT05467150?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-10-17. Estimated completion is 2026-08-31.
What conditions does trial NCT05467150 study?
This clinical trial studies the following conditions: Infant of Diabetic Mother.
What interventions are being tested in trial NCT05467150?
The interventions under investigation include: Probiotic Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05467150?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05467150 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05467150's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI